Leon Aarons

The influence of body weight on the pharmacokinetics of mefloquine.

R. Price, L. Aarons, J. Simpson, 2002, British journal of clinical pharmacology.

Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies

M. Rowland, L. Aarons, L. Aarons, 2004, European Journal of Clinical Pharmacology.

Role of modelling and simulation in Phase I drug development.

L Aarons, M O Karlsson, F Mentré, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Population approaches in drug development

L Aarons, F Mentré, J L Steimer, 1994, European Journal of Clinical Pharmacology.

Proper lumping in systems biology models.

L. Aarons, A. Dokoumetzidis, Leon Aarons, 2009, IET systems biology.

Population pharmacokinetic/pharmacodynamic models for duloxetine in the treatment of diabetic peripheral neuropathic pain

Ivelina Gueorguieva, Leon Aarons, Eunice Yuen, 2013, European journal of pain.

The estimation of population pharmacokinetic parameters using an EM algorithm.

Leon Aarons, 1993, Computer methods and programs in biomedicine.

Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

L. Aarons, E. Chan, M. Rowland, 1987, British journal of clinical pharmacology.

Whole body physiologically based modelling of β‐blockers in the rat: events in tissues and plasma following an i.v. bolus dose

L. Aarons, M. Rowland, G. Dickinson, 2018, British journal of pharmacology.